Use of the adenosine A2a receptor agonist, CGS 21680, suggested a role for this receptor in preventing GVHD progression, but this result was confounded by this agonist increasing weight loss in Hu-PBMC-NSG mice (Geraghty et al., 2019a). This evidence concerns the gene ADORA2A and graft versus host disease.